Our subsidiaries

Julphar’s vertical integration means that we manufacture, distribute and sell our products. We control every aspect of our supply chain, which translates into competitive pricing, efficient delivery and quality products.

Our subsidiary, Planet Pharmacies, is a vital part of our supply chain. A wholesaler and one of the leading pharmacy chains in the region, it was established in 2007 and serves a range of segments within the healthcare sector including pharmaceuticals, nutraceuticals and medical devices. Today, Planet Pharmacies has a retail and distribution presence in the UAE, Saudi Arabia and Oman and its 200 pharmacies employ more than 800 people.


For more information, please visit www.planetme.ae





The pharmaceutical sector is a continuously changing industry that faces increasing supply chain challenges – from temperature control to specialized handling and transport solutions. At Julphar, we never compromise on quality, which is why the transportation of our products is such an important part of the supply chain.


Our transport and shipping division, MenaCool, transports our products by land, sea and air all across the globe and ensures that our medicines are delivered on time from origin to end point. We offer 24/7 service dispatch by road to countries all across the Middle East and Africa and our 40 trucks are supported by air and sea freight for cold chain products.

Gulf Inject

Gulf Inject manufactures and distributes world-class IV fluids and is a leader in fluid management therapy in the Middle East and North Africa. Founded in Dubai in 1994, its products and services care for critical and chronically ill patients.


Gulf Inject’s portfolio comprises more than 50 products, including generic intravenous solutions, fourth generation antibiotics in injectable form and new innovative molecules in solid dosage forms. The company annually produces 35 million ampoules and 7.2m IV bottles and also handles the secondary packaging of 25m tablets and capsules. Gulf Inject has been a 100 per cent subsidiary of Julphar since June 2017.



This website intends to use cookies to improve the site and your experience. By continuing to browse the site you are agreeing to accept our use of cookies. If you require further information and/or do not wish to have cookies placed when using the site, refer to our Cookie Policy.